Study on liver tissue derived-extracellular vesicles regulating the osteogenic differentiation ability of mesenchymal stem cells and promoting the healing of jaw bone defects
Objective To explore the biological process of liver tissue-derived extracellular vesicle(LT-EV)in promoting osteogenic differentiation of mesenchymal stem cells and healing of jaw defects to provide a feasible treatment method for the clinical treatment of jaw bone defects.Methods Enzymatic hydrolysis and differential centrifugation were used to extract LT-EV,scanning electron microscopy,Western blotting,and nanoparticle tracking analyzers were used to identify and characterize LT-EV,and further to explore the biological functions of LT-EV through proteomics and Kyoto Encyclopedia of Genes and Genomes.Flow cytometry was used to detect LT-EV plasma concentration and to calculate the plasma half-life of LT-EV.Small animal in vivo imaging system was used to detect the biological distribution of LT-EV 24 hours after injection.Six C57BL/6 mice were divided into control group and LT-EV group(3 mice in each group)by simple random sampling method.All mice underwent jaw bone defect surgery and tail vein injection every 7 days(the control group was injected with phosphoric buffer saline,LT-EV group was injected with LT-EV),micro-CT was used to evaluate the degree of mouse jaw bone healing 28 days after surgery,HE staining was used to analyze the multi-organ biosafety of LT-EV,and immunofluorescence staining was used to detect the jaw bone expression of osteogenic marker proteins in the defect area.Human jaw bone mesenchymal stem cells(hJBMSC)induced by osteogenic differentiation were treated with LT-EV(obtained from orthognathic surgery patients provided by the Department of Traumatology and Orthognathic Surgery of School of Stomatology of The Fourth Military Medical University resected normal jaw bone fragments),and the difference in osteogenic differentiation ability between the hJBMSC group and the control group(phosphate buffer saline treatment)was compared,and the in vitro bone differentiation promoting effect of LT-EV was verified through alkaline phosphatase(ALP)staining and real-time fluorescence quantitative PCR.Results The yield of LT-EV was high,and proteomics and Kyoto Encyclopedia of Genes and Genomes showed that LT-EV contained a series of proteins that regulated cell biological functions.LT-EV injected into the tail vein could reach the mouse jaw bone defect area and promote the regeneration and repair of the jaw bone defect[the bone volume fractions of the LT-EV group and the control group were(36.06± 4.20)％and(18.58±5.61)％,respectively;t=4.32,P=0.013],and had good biosafety.LT-EV could promote osteogenic differentiation of hJBMSC in vitro.Compared to the control group,ALP staining and osteogenic gene expression levels were significantly enhanced after osteogenic differentiation of hJBMSC(P＜0.05).Conclusions LT-EV exhibits a high yield,ease of acquisition,high biological safety,and excellent bone-promoting effects.It holds promise as a novel cell-free therapy strategy for regenerating craniofacial bone defects.
Bone regenerationRegenerative medicineLiverExtracellular vesiclesMesenchymal stem cellsOsteogenic differentiation
NETL
NSTL
万方数据
